Leronlimab Administration Leronlimab 700 mg was administered via 2 abdominal subcutaneous injections of 350 mg each, with repeat dosing if they remained hospitalized after 7 days. All treatment decisions and laboratory monitoring were left to the discretion of the physicians caring for the patients. 2 (two) not 4 (four) correct? https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1583/5932277